The results of the present study—indicating a relationship between the DRD2 co-expression network and an established phenotype linked to schizophrenia such as PET-estimated dopamine synthesis capacity—are consistent with the hypothesis of the involvement of the genes of this module in the pathophysiology of schizophrenia and mechanisms underlying the response to antipsychotics. Here, DRD2 is linked to schizophrenia.